<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">25025</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2020-24-4-304-314</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL PHYSIOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ ФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Regulatory cytokine effects in vitro on the phenotype of subpopulations CD62L+CD63-, CD62L+CD63+ and microbicidal activity of neutrophilic granulocytes in patients with colorectal cancer</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности влияний in vitro регуляторных цитокинов на фенотип субпопуляций CD62L+CD63-, CD62L+CD63+ и микробицидную активность нейтрофильных гранулоцитов пациентов с колоректальным раком</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="spin">2092-6412</contrib-id><name-alternatives><name xml:lang="en"><surname>Chudilova</surname><given-names>G. A.</given-names></name><name xml:lang="ru"><surname>Чудилова</surname><given-names>Г. А.</given-names></name></name-alternatives><email>chudilova2015@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">4714-2488</contrib-id><name-alternatives><name xml:lang="en"><surname>Nesterova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Нестерова</surname><given-names>И. В.</given-names></name></name-alternatives><email>chudilova2015@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">8289-5342</contrib-id><name-alternatives><name xml:lang="en"><surname>Kovaleva</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Ковалева</surname><given-names>С. В.</given-names></name></name-alternatives><email>chudilova2015@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="spin">2060-9316</contrib-id><name-alternatives><name xml:lang="en"><surname>Lomtatidze</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Ломтатидзе</surname><given-names>Л. В.</given-names></name></name-alternatives><email>chudilova2015@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kuban State Medical University</institution></aff><aff><institution xml:lang="ru">Кубанский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>24</volume><issue>4</issue><issue-title xml:lang="en">EXPERIMENTAL AND CLINICAL  PHYSIOLOGY</issue-title><issue-title xml:lang="ru">ЭКСПЕРИМЕНТАЛЬНАЯ И КЛИНИЧЕСКАЯ ФИЗИОЛОГИЯ</issue-title><fpage>304</fpage><lpage>314</lpage><history><date date-type="received" iso-8601-date="2020-11-23"><day>23</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Chudilova G.A., Nesterova I.V., Kovaleva S.V., Lomtatidze L.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Чудилова Г.А., Нестерова И.В., Ковалева С.В., Ломтатидзе Л.В.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Chudilova G.A., Nesterova I.V., Kovaleva S.V., Lomtatidze L.V.</copyright-holder><copyright-holder xml:lang="ru">Чудилова Г.А., Нестерова И.В., Ковалева С.В., Ломтатидзе Л.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/25025">https://journals.rudn.ru/medicine/article/view/25025</self-uri><abstract xml:lang="en"><p>Relevance. Neutrophilic granulocytes (NG) are the first cells of the immune system to migrate to the tumor and are actively involved in the implementation of a full-fledged antitumor response through the mechanisms of direct killing of tumor cells, extracellular lysis (NET), and through the activation of antibody-dependent cellular cytotoxicity (ADCC), inhibition of angiogenesis, initiation of other cells with antitumor activity. The aim of the study was to study the effect of cytokines IFNα, IFNγ, G-CSF on the CD62L+CD63- and CD62L+CD63+ subsets and the microbicidal activity of NGs in patients with colorectal cancer (CRC) in vitro. Materials and methods. We studied samples of peripheral blood (PB) of 10 patients of both sexes 38-70 years old with newly diagnosed untreated CRC stage II-III (study group) and 10 healthy volunteers (comparison group). The subsets CD62L+CD63+ NG, CD62L+CD63- NG were assessed by flow cytometry (CYTOMICS FC500, Beckman Coulter, USA), the microbicidal functions of NG were tested by cytochemical methods: activity of NADPH - oxidases, myeloperoxidase (MP), level of cationic protein (CP) in spontaneous tests and under additional stress of S. aureus . The effect of IFNα, IFNγ, G-CSF cytokines on subsets and the microbicidal activity of NG in vitro was studied in both study groups. Microsoft Exel 2016 and StatPlus 2010 were used for statistical processing of the obtained data using nonparametric tests: Me (Q1; Q3), Mann-Whitney U-test and Wilcoxon test . Results . The features of transformation of CD62L+ CD63-NG and CD62L+ CD63+ NG subsets of PB in CRC have been established, that allows to get an idea of the NG ability to roll and readiness to activate the microbicidal arsenal, various defects of spontaneous and induced microbicidal activity of oxygendependent and oxygen-independent mechanisms of NG. The effects of cytokine influence on NG in CRC in vitro have been shown, which indicates the possibility of regulating the receptor and microbicidal functions of NG, and, on the other hand, suggests defects in NG perception of regulatory stimuli, that is confirmed by the progression of tumor growth.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Нейтрофильные гранулоциты (НГ) первыми из клеток иммунной системы мигрируют к опухоли и активно вовлекаются в реализацию полноценного противоопухолевого ответа через механизмы прямого киллинга клеток опухоли, внеклеточного лизиса (NET), так и через активацию антителозависимой клеточной цитотоксичности (АЗКЦ), ингибирование ангиогенеза, инициации других клеток, обладающих противоопухолевой активностью. Цель: изучить влияние цитокинов IFNa, IFNg, G-CSF на субпопуляции CD62L+CD63- и CD62L+CD63+ и микробицидную активность НГ пациентов с колоректальным раком (КРР) в системе in vitro. Материалы и методы . Исследованы образцы периферической крови (ПК) 10 пациентов обоего пола 38-70 лет с впервые выявленным нелеченым КРР II-III стадии (группа исследования) и 10 условно-здоровых добровольцев (группа сравнения). Проведена оценка субпопуляций CD62L+CD63+НГ, CD62L+CD63-НГ методом проточной цитометрии (CYTOMICS FC500, Beckman Coulter, США), цитохимическими методами тестировались микробицидные функции НГ: активность NADPH-оксидаз, миелопероксидазы (МП), уровень катионного белка (КБ) в спонтанных тестах и при дополнительной нагрузке S.aureus . В обеих исследуемых группах изучалось влияние цитокинов IFNα, IFNγ, G-CSF на субпопуляции и микробицидную активность НГ системе in vitro. Данные подвергали обработке непараметрическими методами статистики с помощью программ Microsoft Exel 2016 и StatPlus 2010, результаты представлены как медиана с интерквартильным размахом - Ме (Q1; Q3). Значимость различий между группами рассчитывали с использованием U-критерия Манна-Уитни и критерия Вилкоксона. Результаты . Установлены особенности трансформации субпопуляций CD62L+CD63-НГ и CD62L+CD63+НГ ПК при КРР, позволяющие получить представление о способности НГ к роллингу и готовности активировать микробицидный арсенал, различные дефекты спонтанной и индуцированной микробицидной активности кислород зависимых и кислород независимых механизмов НГ. В эксперименте in vitro показаны эффекты влияния цитокинов на НГ при КРР, что свидетельствуют о возможности регулирования рецепторных и микробицидных функций НГ, с другой стороны, позволяют говорить о дефектах восприятия НГ регулирующих стимулов, что подтверждается прогрессированием опухолевого роста.</p></trans-abstract><kwd-group xml:lang="en"><kwd>colorectal cancer</kwd><kwd>neutrophilic granulocytes</kwd><kwd>subset</kwd><kwd>cytokines</kwd><kwd>microbicidal functions</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>колоректальный рак</kwd><kwd>нейтрофильные гранулоциты</kwd><kwd>субпопуляции</kwd><kwd>цитокины</kwd><kwd>микробицидные функции</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was funded by the Ministry of health of the Russian Federation (project no. AAAA-A18–118122690053–0).</funding-statement><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания Министерства здравоохранения Российской Федерации (проект № АААА-А18–118122690053–0).</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Cancer Research UK. Cancer statistics. available at: www. cancerresearchuk.org. Access date: 10/08/2020.</mixed-citation><mixed-citation xml:lang="ru">Cancer Research UK. Cancer statistics. available at: www. cancerresearchuk.org. Дата доступа: 10/08/2020.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Mantovani A., Romero P., Palucka A.K., Marincola F.M. Tumour immunity: effector response to tumor and role of the microenvironment. Lancet. 2008; 371:771–783.</mixed-citation><mixed-citation xml:lang="ru">Mantovani A., Romero P., Palucka A.K., Marincola F.M. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet. 2008. V. 371. P. 771-783.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">McLean M.H., Murray G.I., Stewart K.N., Norrie G., Mayer C., Hold G.L., Thomson J., Fyfe H., Mowat N.A., Drew E.J., El-Omar M.E. The inflammatory microenvironment in colorectal neoplasia. PLoS One. 2011;6(1): e15366. doi:10.1371/journal.pone.0015366.</mixed-citation><mixed-citation xml:lang="ru">McLean M.H., Murray G.I., Stewart K.N., Norrie G., Mayer C., Hold G.L., Thomson J., Fyfe H., Mowat N.A., Drew E.J., ElOmar M.E. The inflammatory microenvironment in colorectal neoplasia. PLoS One. 2011. V.6(1): e15366. doi:10.1371/journal. pone.0015366.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Swierczak A., Mouchemore K.A., Hamilton J.A., Anderson R.L. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis. 2015;34:735–751. doi:10.1007/ s10555–015–9594–9</mixed-citation><mixed-citation xml:lang="ru">Swierczak A., Mouchemore K.A., Hamilton J.A., Anderson R.L. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis. 2015. V. 34. P. 735-751. doi:10.1007/s10555-015-9594-9</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Sionov R.V., Fridlender Z.G., Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015;8:125–158. doi:10.1007/s12307–014–0147–5</mixed-citation><mixed-citation xml:lang="ru">Sionov R.V., Fridlender Z.G., Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015. V. 8. P. 125-158. doi:10.1007/s12307- 014-0147-5</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Coffelt S.B., Wellenstein M.D., de Visser K.E. Neutrophils in cancer: neutral no more. Nat. Rev. Cancer. 2016;16:431–446. doi:10.1038/nrc.2016.52</mixed-citation><mixed-citation xml:lang="ru">Coffelt S.B., Wellenstein M.D., de Visser K.E. Neutrophils in cancer: neutral no more. Nat. Rev. Cancer. 2016. V. 16. P. 431-446. doi:10.1038/nrc.2016.52</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Mishalian I., Granot Z., Fridlender Z.G. The diversity of circulating neutrophils in cancer. Immunobiology. 2017;222:82–88. doi:10.1016/j.imbio.2016.02.001</mixed-citation><mixed-citation xml:lang="ru">Mishalian I., Granot Z., Fridlender Z.G. The diversity of circulating neutrophils in cancer. Immunobiology. 2017. V. 222. P. 82-88. doi:10.1016/j.imbio.2016.02.001</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Kabayashi Y. The role of chemokines in neutrophil biology Frontiers in bioscience: a journal and virtual library. 2008;13:2400–2407.</mixed-citation><mixed-citation xml:lang="ru">Kabayashi Y. The role of chemokines in neutrophil biology. Frontiers in bioscience: a journal and virtual library. 2008. V. 13. P. 2400-2407.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Khajah M., Millen B., Cara D.C., Waterhouse C., Mc Cafferty D. Granulocyte-macrophage colony-stimulating factor (GM–CSF): a chemoattractive agent for murine leukocytes in vivo. Journal of Leukocyte Biology. 2011; 89 (6):945–953.</mixed-citation><mixed-citation xml:lang="ru">Khajah M., Millen B., Cara D.C., Waterhouse C., Mc Cafferty D. Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo. Journal of Leukocyte Biology. 2011. V. 89 (6). P. 945-953.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Dumitru C.A., Lang S., Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Seminars in Cancer Biology. 2013;23:141–148.</mixed-citation><mixed-citation xml:lang="ru">Dumitru C.A., Lang S., Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Seminars in Cancer Biology. 2013. Vol. 23. P. 141-148.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Mishalian I., Granot Z., Fridlender Z.G. The diversity of circulating neutrophils in cancer.Immunobiology. 2017;222 (1):82–88.</mixed-citation><mixed-citation xml:lang="ru">Mishalian I., Granot Z., Fridlender Z.G. The diversity of circulating neutrophils in cancer. Immunobiology. 2017. V. 222 (1). P. 82-88.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang X., Zhang W., Yuan X., Fu M., Qian H., Xu W. Neutrophils in cancer development and progression: Roles, mechanisms, and implications (Review). International journal of oncology. 2016; 49(3):857–867.</mixed-citation><mixed-citation xml:lang="ru">Zhang X., Zhang W., Yuan X., Fu M., Qian H., Xu W. Neutrophils in cancer development and progression: Roles, mechanisms, and implications (Review). International journal of oncology. 2016. V. 49(3). P. 857-867.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Lau D., Mollnau H., Eiserich J.P., Freeman B.A., Daiber A., Gehling U.M., Brümmer J., Rudolph V., Münzel T., Heitzer T., Meinertz T., Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proceedings of the National Academy of Sciences. 2005;102 (2):431–436.</mixed-citation><mixed-citation xml:lang="ru">Lau D., Mollnau H., Eiserich J.P., Freeman B.A., Daiber A., Gehling U.M., Brümmer J., Rudolph V., Münzel T., Heitzer T., Meinertz T., Baldus S. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proceedings of the National Academy of Sciences. 2005. V.102 (2). Р.431-436.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Mantovani А. The yin-yang of tumor-associated neutrophils. Cancer Cell. 2009;8:173–174.</mixed-citation><mixed-citation xml:lang="ru">Mantovani А. The yin-yang of tumor-associated neutrophils. Cancer Cell. 2009. V. 8. Р.173-174.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Levy O. Innate immunity of the newborn: basic mechanisms clinical correlates. Nature reviews Immunology. 2007;7(5): 379–390.</mixed-citation><mixed-citation xml:lang="ru">Levy O. Innate immunity of the newborn: basic mechanisms clinical correlates. Nature reviews Immunology. 2007. V. 7(5). P. 379-390.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Lin A., Lore K. Granulocytes: New Members of the AntigenPresenting Cell Family. Frontiers in Immunology. 2017;11. doi:10.3389/fimmu.2017.01781</mixed-citation><mixed-citation xml:lang="ru">Lin A., Lore K. Granulocytes: New Members of the AntigenPresenting Cell Family. Frontiers in Immunology. 2017. V. 11. doi:10.3389/fimmu.2017.01781</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Dallegri F., Ottonello L., Ballesterro A., Patrizia Dapino, F. Ferrando, F. Patrone, C. Sacchetti Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen. Inflammation. 1991; 1(15):15–30.</mixed-citation><mixed-citation xml:lang="ru">Dallegri F., Ottonello L., Ballesterro A., Patrizia Dapino, F. Ferrando, F. Patrone, C. Sacchetti Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen. Inflammation. 1991. V. 1. № 15. P. 15-30.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Lai X., Gu Q., Zhou X., Feng W., Lin X., He Y., Cao J., Liu P., Zhang H., Zheng X. Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. Oncol Lett. 2017;13(6):4245–4251. DOI: 10.3892/ol.2017.6023.</mixed-citation><mixed-citation xml:lang="ru">Lai X., Gu Q., Zhou X., Feng W., Lin X., He Y., Cao J., Liu P., Zhang H., Zheng X. Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. Oncol Lett. 2017. V. 13(6). Р. 4245-4251. doi: 10.3892/ ol.2017.6023.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Liu W.H., Li X., Zhu X.L., Hou M.L., Zhao W. CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma. Oncol Lett. 2018;(6): 9033–9042. DOI: 10.3892 / ol.2018.8499.</mixed-citation><mixed-citation xml:lang="ru">Liu W.H., Li X., Zhu X.L., Hou M.L., Zhao W. CD63 inhibits the cell migration and invasion ability of tongue squamous cell carcinoma. Oncol Lett. 2018. V.(6). P. 9033-9042. doi: 10.3892 / ol.2018.8499.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Beinert T., Munzing S., Possinger K., Krombach F. Increased expression of the tetraspanins CD53 and CD63 on apoptotic human neutrophils.Journal of Leukocyte Biology. 2000; 67:369–373.</mixed-citation><mixed-citation xml:lang="ru">Beinert T., Munzing S., Possinger K., Krombach F. Increased expression of the tetraspanins CD53 and CD63 on apoptotic human neutrophils. Journal of Leukocyte Biology. 2000. V. 67. P. 369-373.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Droeser R.A., Hirt C., Eppenberger-Castori S., Zlobec I., Viehl C.T., Frey D.M., Nebiker C.A., Rosso R., Zuber M., Amicarella F. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One. 2013; 8: e64814.</mixed-citation><mixed-citation xml:lang="ru">Droeser R.A., Hirt C., Eppenberger-Castori S., Zlobec I., Viehl C.T., Frey D.M., Nebiker C.A., Rosso R., Zuber M., Amicarella F. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One. 2013. V. 8. e64814.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Roncucci L., Mora E., Mariani F., Bursi S., Pezzi A., Rossi G., Pedroni M., Luppi D., Santoro L., Monni S. Myeloperoxidasepositive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2291–2297.</mixed-citation><mixed-citation xml:lang="ru">Roncucci L., Mora E., Mariani F., Bursi S., Pezzi A., Rossi G., Pedroni M., Luppi D., Santoro L., Monni S. Myeloperoxidasepositive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2008. V. 17. P. 2291-2297.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Rao H.L., Chen J.W., Li M., Xiao Y.B., Fu J., Zeng Y.X., Cai M.Y., Xie D. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients’ adverse prognosis. PLoS One. 2012;7: e30806</mixed-citation><mixed-citation xml:lang="ru">Rao H.L., Chen J.W., Li M., Xiao Y.B., Fu J., Zeng Y.X., Cai M.Y., Xie D. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients’ adverse prognosis. PLoS One. 2012. V. 7. e30806.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Gustafson M.P., Lin Y., Maas M.L., Van Keulen V.P., Johnston P.B., Peikert T., Gastineau D.A., Dietz A.B. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015; 10: e0121546.</mixed-citation><mixed-citation xml:lang="ru">Gustafson M.P., Lin Y., Maas M.L., Van Keulen V.P., Johnston P.B., Peikert T., Gastineau D.A., Dietz A.B. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015. V. 10. e0121546.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
